Wendy Kampman, MD, serves as Chief Medical Affairs Officer for QED and Calcilytix at BridgeBio, focusing on the advancement of innovative therapies for rare genetic conditions. Previously, Wendy held the position of Vice President of Medical Affairs at Vertex Pharmaceuticals and spent nearly a decade at Regeneron, where roles included Vice President of Global Medical Communications and Global Medical Franchise Lead, overseeing multiple therapeutic areas. Early career experience includes leadership positions in medical affairs at Bristol Myers Squibb and AbbVie, alongside clinical roles in pediatric intensive care at Guy's and St Thomas' NHS Foundation Trust. Wendy's educational credentials encompass a Doctor of Medicine from Vrije Universiteit Brussel, board certifications in pediatrics, and advanced training in pharmaceutical medicine and executive coaching.
This person is not in the org chart
This person is not in any teams
This person is not in any offices